Stockscreener 앱 받기
1.13
8.87%
-0.11
시간 외 거래:
1.14
0.01
+0.88%
전일 마감가:
$1.24
열려 있는:
$1.22
하루 거래량:
461.97K
Relative Volume:
16.21
시가총액:
$28.74M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-12.40%
1개월 성능:
+0.00%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$1.1208
$1.2438
1주일 범위
$1.1208
$1.39
52주 변동 폭
$1.1208
$1.39
Lunai Bioworks Inc Stock (LNAI) Company Profile
명칭
Lunai Bioworks Inc
전화
45 39179840
주소
CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES
LNAI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LNAI
Lunai Bioworks Inc
|
1.13 | 28.74M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Lunai Bioworks Inc 주식(LNAI)의 최신 뉴스
Lunai Bioworks reports 35% improvement in Alzheimer’s diagnostics - Investing.com
Lunai Bioworks Launches AI-Powered Alzheimer's Disease Program, Expanding Neurodegenerative Pipeline - PharmiWeb.com
Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery - Online Athens
Seven new option listings and two option delistings on October 1st - TipRanks
LNAI Stock Price and Chart — NASDAQ:LNAI - TradingView
Lunai Bioworks Unveils New Corporate Identity, Streamlined Capital Structure, and Strategic Focus on - PharmiWeb.com
AI Drug Discovery Pioneer Lunai Bioworks Emerges with New Identity and Streamlined 23.2M Share Structure - Stock Titan
Analyzing Climb Bio (NASDAQ:CLYM) & Lunai Bioworks (NASDAQ:RENB) - Defense World
Renovaro Biosciences Announces Reverse Stock Split - TipRanks
Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split - PharmiWeb.com
Lunai Bioworks to effect 10:1 reverse stock split - MSN
Lunai Bioworks stock plunges after announcing 10:1 reverse split By Investing.com - Investing.com UK
$1.85M NIH Grant Powers Lunai Bioworks' AI Platform to Combat Alcohol Disorder Affecting 19M Americans - Stock Titan
Top 3 Health Care Stocks You'll Regret Missing In Q3 - Sahm
Lunai Bioworks launches transformer-base platform to secure GenAI - Yahoo Finance
Lunai Bioworks (RENB) Restructures European Operations for Strat - GuruFocus
AI Drug Discovery Firm Lunai Bioworks Restructures European Business, Maintains Growth Strategy - Stock Titan
Renovaro Biosciences Faces Subsidiary Bankruptcy Impact - TipRanks
Lunai Bioworks Inc. Retains American Defense International - PharmiWeb.com
User - FinancialContent
Renovaro Inc. changes corporate name to Lunai Bioworks Inc., maintains Nasdaq symbol - Investing.com
Merger Crisis: Renovaro Threatens Legal Action After Predictive Oncology Backs Out - Stock Titan
RENBRenovaro Latest Stock News & Market Updates - Stock Titan
Enochian Biosciences Is A House Of CardsThe Pipeline Is Entirely Pre-Clinical And Management Has A Questionable History (NASDAQ:RENB) - Seeking Alpha
Lunai Bioworks Inc (LNAI) 재무 분석
Lunai Bioworks Inc (LNAI)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
5.74%
자본화:
|
볼륨(24시간):